At the Cambridge diabetes seminar in Kochi, Mithal faced Prof Bill Herman of the University of Michigan, with the audience joining in.
Recap by typeshit. Post by Dr Ambrish Mithal on X.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Fierce Pharma's weekly tracker, using IQVIA data via Citi and Jefferies, has Zepbound still far ahead at about 801.8K total scripts.
GoodRx keeps a running page on peptide regulation news, with a focus on what the FDA is doing about compounding pharmacies.
Loading…